UNSPSC 85815010: Introduction of anti-inflammatory into products of conception, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into products of conception, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0E83Z

UNSPSC 85815010 Introduction of anti-inflammatory into products of conception, via natural or artificial opening endoscopic is a Commodity code that sees minimal relevant state and local procurement activity. The code's highly specialized clinical scope—interventional obstetric and gynecological procedures using endoscopic delivery of anti-inflammatory agents—does not align with the recent opportunities posted under this classification. The one opportunity directly tagged to this code, Inland Empire Health Plan's virtual urgent care RFI (posted October 16, 2026, response due October 31, 2026), solicits telehealth evaluation and management services with medication prescription authority, not procedural anti-inflammatory intervention. The remaining opportunities in the dataset span occupational health services, emergency medical services, cancer screening, behavioral health, opioid treatment, nursing home operations, and various other health services—none of which involve endoscopic anti-inflammatory delivery into products of conception or match the code's nominal scope.

State and local buyers posting under this code include a California health plan, Georgia county government, Nevada health authority, and other county and municipal health systems. However, the mismatch between code designation and actual work performed suggests either data-entry error in the procurement system or mission creep in code assignment that does not reflect current buying patterns. Buyers appear concentrated in California, Georgia, Nevada, and scattered across Florida, Colorado, Arizona, and other states, but the geographic distribution reflects general health services procurement activity rather than demand specific to anti-inflammatory endoscopic procedures. Without recent solicitations for work actually falling within this code's technical definition, the code presents minimal market opportunity for specialized obstetric procedural service providers.